WO2019034377A1 - Composition de soin bucco-dentaire - Google Patents

Composition de soin bucco-dentaire Download PDF

Info

Publication number
WO2019034377A1
WO2019034377A1 PCT/EP2018/069990 EP2018069990W WO2019034377A1 WO 2019034377 A1 WO2019034377 A1 WO 2019034377A1 EP 2018069990 W EP2018069990 W EP 2018069990W WO 2019034377 A1 WO2019034377 A1 WO 2019034377A1
Authority
WO
WIPO (PCT)
Prior art keywords
calcium
phosphate
source
oral care
care composition
Prior art date
Application number
PCT/EP2018/069990
Other languages
English (en)
Inventor
Xiaoke Li
Jinfang Wang
Huaiyong XING
Original Assignee
Unilever N.V.
Unilever Plc
Conopco, Inc., D/B/A Unilever
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever N.V., Unilever Plc, Conopco, Inc., D/B/A Unilever filed Critical Unilever N.V.
Priority to CN201880060433.2A priority Critical patent/CN111093603B/zh
Priority to BR112020002930-0A priority patent/BR112020002930B1/pt
Priority to EA202090522A priority patent/EA202090522A1/ru
Priority to EP18742507.9A priority patent/EP3668478B1/fr
Publication of WO2019034377A1 publication Critical patent/WO2019034377A1/fr
Priority to PH12020500258A priority patent/PH12020500258A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention relates to oral care compositions such as tooth pastes, powders, gums, mouthwashes and the like.
  • the present invention relates to an oral care composition comprising a water insoluble and/or slightly soluble calcium source, a water soluble calcium source and a phosphate source that results in reducing tooth sensitivity and/or tooth remineralization.
  • This invention also relates to the use of such compositions for treating tooth hypersensitivity and/or remineralizing and/or whitening of teeth of an individual.
  • Tooth hypersensitivity is a temporary induced pain sensation that affects up to 20% of the adult population.
  • Hypersensitive teeth may be sensitive to temperature, pressure or chemical action.
  • the dentin of the tooth generally contains channels, called tubules, which provide for an osmotic flow between the inner pulp region of the tooth and the outer root surfaces.
  • Tooth hypersensitivity may be related to the general increase in exposed root surfaces of teeth as a result of periodontal disease, toothbrush abrasion, or cyclic loading fatigue of the thin enamel near the dentin-enamel junction. When root surfaces are exposed, dentinal tubules are also exposed.
  • the currently accepted theory for tooth hypersensitivity is the hydrodynamic theory, based on the belief that open exposed dentinal tubules allow fluid flow through the tubules. This flow excites the nerve endings in the dental pulp.
  • Clinical replica of sensitive teeth viewed in a SEM (scanning electron microscopy) reveal varying numbers of open or partially occluded dentinal tubules.
  • tooth hypersensitivity There are different approaches to treat tooth hypersensitivity.
  • One approach is to reduce the excitability of the nerve in a sensitive tooth by using "nerve-depolarising agents" comprising strontium ions, potassium salts such as potassium nitrate, potassium bicarbonate, potassium chloride and the like. These nerve-depolarising agents function by interfering with neural transduction of the pain stimulus to make the nerve less sensitive.
  • tubule blocking agents that fully or partially occlude tubules such as polystyrene beads, apatite, polyacrylic acid, mineral hectorite clay and the like. These tubule blocking agents function by physically blocking the exposed ends of the dentinal tubules, thereby reducing dentinal fluid movement and reducing the irritation associated with the shear stress described by the hydrodynamic theory. There is a continuing need for treating tooth hypersensitivity with a more efficient approach.
  • an oral care composition comprising a water insoluble and/or slightly soluble calcium source, a water soluble calcium source and a phosphate source provides excellent tubule blockage efficacy to reduce tooth sensitivity.
  • such composition may also enhance the tooth remineralization efficacy and/or the deposition of benefit agents on tooth surfaces to further benefit teeth of an individual.
  • WO 2008/068149 A discloses an oral care product comprising a first composition comprising an insoluble calcium salt that is not a calcium phosphate salt, a second independent composition comprising a source of phosphate ions, and a means for delivering each of the compositions to the surface of the teeth.
  • the preferred insoluble calcium salt is calcium silicate.
  • an oral care composition comprising a water insoluble and/or slightly soluble calcium source, a water soluble calcium source, a phosphate source and a physiologically acceptable carrier, wherein the water insoluble and/or slightly soluble calcium source comprises calcium carbonate, calcium aluminate, calcium oxalate, aluminium calcium silicate, calcium oxide, calcium carboxymethyl cellulose, calcium alginate, calcium hydroxide, calcium sulfate, calcium salts of citric acid or mixtures thereof, and wherein the water insoluble and/or slightly soluble calcium source and the water soluble calcium source are present in a weight ratio from 1 :3 to 20:1 , wherein the water insoluble and/or slightly soluble calcium source has a D50 particle size of from 0.01 to 3 microns, and wherein the phosphate source is trisodium phosphate, monosodium dihydrogen phosphate, disodium hydrogen phosphate, ammonium phosphate, diammonium hydrogen phosphate, ammonium dihydr
  • Densink for the purposes of the present invention means a paste, powder, liquid, gum or other preparation for cleaning the teeth or other surfaces in the oral cavity.
  • Tooth paste for the purpose of the present invention means a paste or gel dentifrice for use with a toothbrush. Especially preferred are tooth pastes suitable for cleaning teeth by brushing for about two minutes.
  • Particle size for the purpose of the present invention means D50 particle size.
  • the D50 particle size of a particulate material is the particle size diameter at which 50 wt% of the particles are larger in diameter and 50 wt% are smaller in diameter.
  • particle sizes and distribution of the water insoluble and/or slightly soluble calcium source are using Sedigraph Series 51 through sedimentation analysis.
  • the sample to be analysed is introduced as a suspension into the sedimentation cell through a peristaltic pump.
  • a finely collimated beam of X-ray passes through the suspended medium.
  • the concentration of sediment in the beam is proportional to the X- ray intensity.
  • the software of the instrument solves stokes' Law and presents the final result linearly as a cumulative mass percent distribution.
  • Composite particle for the purpose of the present invention means a particle comprising a first component core and a second component coating wherein the core and coating are composed of different materials. Refractive Index
  • Refractive index is quoted at a temperature of 25°C and a wavelength of 589 nm.
  • pH is quoted at atmospheric pressure and a temperature of 25°C.
  • the pH may be measured by manually mixing 5 g oral care composition with 20 mL water for 30 s, then immediately testing the pH with indicator or a pH meter.
  • Soluble and “insoluble” for the purpose of the present invention means the solubility of a source (e.g., like calcium salts) in water at 25°C and atmospheric pressure.
  • Soluble means a source that dissolves in water to give a solution with a concentration of at least 0.1 moles per litre.
  • Insoluble means a source that dissolves in water to give a solution with a concentration of less than 0.001 moles per litre.
  • substantially free of for the purpose of the present invention means less than 3.0%, and preferably less than 2.0%, and more preferably less than 1 .0% and most preferably less than 0.5% by weight, based on total weight of the oral care composition, including all ranges subsumed therein.
  • Double-Phase for the purpose of the present invention means a composition having two independent phases which are physically separate.
  • Anhydrous composition for the purpose of the present invention means the water content of the composition is less than 3.0%, and preferably less than 2.0%, and more preferably less than 1 .0% and most preferably less than 0.5% by total weight of the oral care composition. Viscosity
  • “Remineralization” for the purpose of the present invention means in situ (i.e. in the oral cavity) generation of calcium phosphate on teeth (including layers on teeth from 10 nm to 20 microns, and preferably from 75 nm to 10 microns, and most preferably, from 150 nm to 5 microns thick including all ranges subsumed therein) to reduce the likelihood of tooth sensitivity, tooth decay, regenerate enamel and/or improve the appearance of teeth by whitening through the generation of such new calcium phosphate.
  • the present invention is directed to an oral care composition
  • an oral care composition comprising: a) a water insoluble and/or slightly soluble calcium source;
  • water insoluble and/or slightly soluble calcium source comprises calcium carbonate, calcium aluminate, calcium oxalate, aluminium calcium silicate, calcium oxide, calcium carboxymethyl cellulose, calcium alginate, calcium hydroxide, calcium sulfate, calcium salts of citric acid or mixtures thereof;
  • water insoluble and/or slightly soluble calcium source and the water soluble calcium source are present in a weight ratio (a:b) from 1 :3 to 20:1 ;
  • water insoluble and/or slightly soluble calcium source has a D50 particle size of from 0.01 to 3 microns
  • the phosphate source is trisodium phosphate, monosodium dihydrogen phosphate, disodium hydrogen phosphate, ammonium phosphate, diammonium hydrogen phosphate, ammonium dihydrogen phosphate, tripotassium phosphate, monopotassium dihydrogen phosphate, dipotassium hydrogen phosphate or a mixture thereof.
  • the present invention is directed to a packaged oral care product comprising the oral care composition of the first aspect of this invention.
  • the present invention is directed to a method for reducing sensitivity and/or remineralization and/or whitening of teeth of an individual comprising the step of applying the oral care composition of any embodiment of the first aspect to at least one surface of the teeth of the individual.
  • an oral care composition comprising a water insoluble and/or slightly soluble calcium source, a water soluble calcium source, and a phosphate source provides excellent tubule blockage efficacy to reduce tooth sensitivity.
  • such composition may also enhance the tooth remineralization efficacy and/or the deposition of benefit agents on tooth surfaces to further benefit teeth of an individual.
  • the water insoluble and/or slightly soluble calcium source suitable for use in this invention is limited only to the extent that the same may be used in the mouth.
  • the calcium source has a D50 particle size of from 0.01 to 3 microns, and preferably from
  • from 1 to 100% by weight of the calcium source used in this invention has a D50 particle size from 0.01 to 1.5 microns.
  • the types of the water insoluble and/or slightly soluble calcium source include, for example, calcium carbonate, calcium aluminate, calcium oxalate, aluminium calcium silicate, calcium oxide, calcium carboxymethyl cellulose, calcium alginate, calcium hydroxide, calcium sulfate, calcium salts of citric acid or mixtures thereof.
  • the water insoluble and/or slightly soluble calcium source comprises at least 80% by weight of calcium carbonate based on total weight of the calcium source. Most preferably, the calcium source comprises from 90 to 100% by weight of calcium carbonate or is calcium carbonate.
  • the oral care composition of the present invention comprises from 0.1 to 80% by weight of the water insoluble and/or slightly soluble calcium source, more preferably from 0.2 to 50%, most preferably from 1 to 30% based on the total weight of the oral care composition and including all ranges subsumed therein.
  • the oral care composition of the present invention comprises from 0.1 to 80% by weight of the water insoluble and/or slightly soluble calcium source having a D50 particle size of 5 microns or less, more preferably from 0.2 to 50%, and most preferably from 1 to 30% based on the total weight of the oral care composition and including all ranges subsumed therein.
  • the water insoluble and/or slightly soluble calcium source having a D50 particle size of greater than 5 microns may be employed in this invention along with the calcium source described herein.
  • the oral care composition of the present invention can comprise from 0.01 to 45%, and preferably from 0.1 to 40%, and most preferably from 5 to 40% by weight of the water insoluble and/or slightly soluble calcium source having a particle size greater than 5 microns and including all ranges subsumed therein. It is within the scope of the present invention for the oral care composition to comprise from 1 to 10% by weight of the water insoluble and/or slightly soluble calcium source like calcium carbonate having a particle size greater than 5 microns and it is further within the scope of the present invention for the oral care composition to be free of the water insoluble and/or slightly soluble calcium source having a particle size of greater than 5 microns.
  • the water soluble calcium source suitable for use in this invention is limited only to the extent that the same may be used in the mouth.
  • the water soluble calcium source is calcium salts in addition to the water insoluble and/or slightly soluble calcium source which is included in the composition.
  • Illustrative yet non-limiting examples of the types of the water soluble calcium source that may be used in this invention include, for example, calcium chloride, calcium nitrate, calcium acetate, calcium lactate, calcium formate, calcium malate, calcium propionate, calcium butyrate, calcium bicarbonate, calcium glycerophosphate, calcium gluconate, calcium ascorbate or mixtures thereof or the like.
  • the calcium source is calcium chloride, calcium nitrate, calcium gluconate, calcium glycerophosphate or mixtures thereof.
  • the oral care composition of the present invention comprises from 0.1 to 20% by weight of the water soluble calcium source, more preferably from 1 to 15%, most preferably from 2 to 10%, based on the total weight of the oral care composition and including all ranges subsumed therein.
  • the oral care composition comprises the water insoluble and/or slightly soluble calcium source and the water soluble calcium source in a weight ratio from 1 :3 to 20:1 , preferably from 1 :3 to 10:1 , more preferably from 1 :1 .5 to 5:1 , and most preferably from 1 :1 to 3:1 .
  • the phosphate source that may be used in this invention is limited only to the extent that the same may be used in a composition suitable for use in the mouth.
  • the phosphate source is able to provide phosphate ions to react with the calcium source to produce a calcium phosphate in situ reaction product that is a precursor for hydroxyapatite formation.
  • the phosphate source suitable for use in this invention includes trisodium phosphate, monosodium dihydrogen phosphate, disodium hydrogen phosphate, ammonium phosphate, diammonium hydrogen phosphate, ammonium dihydrogen phosphate, tripotassium phosphate, monopotassium dihydrogen phosphate, dipotassium hydrogen phosphate, mixtures thereof or the like.
  • the phosphate source is preferably one which is water soluble.
  • the phosphate source When used, the phosphate source typically makes up from 0.1 to 40%, and more preferably, from 0.5 to 30%, and most preferably, from 1 to 20% by weight of the oral care composition, based on total weight of the oral care composition and including all ranges subsumed therein.
  • the phosphate source used is trisodium phosphate and monosodium dihydrogen phosphate at a trisodium phosphate to monosodium dihydrogen phosphate weight ratio of 1 :4 to 4: 1 , preferably 1 :3 to 3: 1 , and most preferably, from 1 :2 to 2: 1 , including all ratios subsumed therein.
  • the phosphate source used is or at least comprises monosodium dihydrogen phosphate.
  • the phosphate source is monopotassium dihydrogen phosphate, dipotassium hydrogen phosphate or a mixture thereof.
  • the phosphate source results in an oral are composition having a pH from 4.0 to 10.0, more preferably from 5.0 to 8.0, and most preferably from 5.5 to 7.5.
  • the oral care composition preferably comprises the water insoluble and/or slightly soluble calcium source and the phosphate source in a weight ratio from 1 : 10 to 30:1 , more preferably from 1 :5 to 20: 1 , most preferably from 1 :3 to 15:1 .
  • the composition of the present invention is an oral care composition and typically comprises a physiologically acceptable carrier.
  • the carrier preferably comprises at least surfactant, thickener, humectant or a combination thereof.
  • the oral care composition comprises a surfactant.
  • the composition comprises at least 0.01 % surfactant by weight of the composition, more preferably at least 0.1 % and most preferably from 0.5 to 7%.
  • Suitable surfactants include anionic surfactants, such as the sodium, magnesium, ammonium or ethanolamine salts of Cs to Ci8 alkyl sulphates (for example sodium lauryl sulphate), Cs to Cis alkyl sulphosuccinates (for example dioctyl sodium sulphosuccinate), Cs to Cis alkyl sulphoacetates (such as sodium lauryl sulphoacetate), Cs to Cis alkyl sarcosinates (such as sodium lauryl sarcosinate), Cs to Cis alkyl phosphates (which can optionally comprise up to 10 ethylene oxide and/or propylene oxide units) and sulphated monoglycerides.
  • anionic surfactants such as the sodium, magnesium, ammonium or ethanolamine salts of Cs to Ci8 alkyl sulphates (for example sodium lauryl sulphate), Cs to Cis alkyl sulphosuccinates (
  • Suitable surfactants include nonionic surfactants, such as optionally polyethoxylated fatty acid sorbitan esters, ethoxylated fatty acids, esters of polyethylene glycol, ethoxylates of fatty acid monoglycerides and diglycerides, and ethylene oxide/propylene oxide block polymers.
  • suitable surfactants include amphoteric surfactants, such as betaines or sulphobetaines. Mixtures of any of the above described materials may also be used. More preferably the surfactant comprises or is anionic surfactant.
  • the preferred anionic surfactants are sodium lauryl sulphate and/or sodium dodecylbenzene sulfonate.
  • the surfactant is sodium lauryl sulphate, sodium coco sulfate, cocamidopropyl betaine, sodium methyl cocoyl taurate or mixtures thereof.
  • Thickener may also be used in this invention and is limited only to the extent that the same may be added to a composition suitable for use in the mouth.
  • Illustrative examples of the types of thickeners that may be used in this invention include, sodium
  • SCMC carboxymethyl cellulose
  • silica based thickeners including silica aerogels, magnesium aluminum silicate (e.g., Veegum), Carbomers (cross-linked acrylates) and mixtures thereof.
  • xanthan gum and/or sodium carboxymethyl cellulose and/or a Carbomer is/are preferred.
  • a Carbomer those having a weight-average molecular weight of at least 700,000 are desired, and preferably, those having a molecular weight of at least 1 ,200,000, and most preferably, those having a molecular weight of at least about 2,500,000 are desired.
  • Mixtures of Carbomers may also be used herein.
  • the Carbomer is Synthalen PNC, Synthalen KP or a mixture thereof. It has been described as a high molecular weight and cross-linked polyacrylic acid and identified via CAS number 9063-87-0. These types of materials are available commercially from suppliers like Sigma.
  • the sodium carboxymethyl cellulose (SCMC) used is SCMC 9H. It has been described as a sodium salt of a cellulose derivative with carboxymethyl groups bound to hydroxy groups of glucopyranose backbone monomers and identified via CAS number 9004-32-4. The same is available from suppliers like Alfa Chem.
  • the thickener is xanthan gum.
  • Thickener typically makes up from 0.01 to about 10%, more preferably from 0.1 to 9%, and most preferably, from 0.1 to 5% by weight of the oral care composition, based on total weight of the composition and including all ranges subsumed therein.
  • the oral care composition of this invention is a toothpaste or gel
  • the same typically has a viscosity from about 30,000 to 180,000 centipoise, and preferably, from 60,000 to 170,000 centipoise, and most preferably, from 65,000 to 165,000 centipoise.
  • Suitable humectants are preferably used in the oral care composition of the present invention and they include, for example, glycerin, sorbitol, propylene glycol, dipropylene glycol, diglycerol, triacetin, mineral oil, polyethylene glycol (preferably, PEG-400), alkane diols like butane diol and hexanediol, ethanol, pentylene glycol, or a mixture thereof.
  • Glycerin, polyethylene glycol, sorbitol or mixtures thereof are the preferred humectants.
  • the humectant may be present in the range of from 10 to 90% by weight of the oral care composition. More preferably, the carrier humectant makes up from 25 to 80%, and most preferably, from 30 to 60% by weight of the composition, based on total weight of the composition and including all ranges subsumed therein.
  • the oral care composition may further comprise benefit agents that are typically delivered to human teeth and/or the oral cavity including the gums to enhance or improve a characteristic of those dental tissues.
  • benefit agents that are typically delivered to human teeth and/or the oral cavity including the gums to enhance or improve a characteristic of those dental tissues.
  • the only limitation with respect to the benefit agents that may be used in this invention is that the same is suitable for use in the mouth.
  • the benefit agents are present in the oral care composition in addition to the water insoluble and/or slightly soluble calcium source and the water soluble calcium source that are included in the composition.
  • the benefit agent is selected from optical agents, biomineralization agents, antibacterial agents, gum health agents, desensitizing agents, anti-calculus agents, freshness agents or mixtures thereof.
  • the benefit agent is selected from optical agents, biomineralization agents, antibacterial agents, gum health agents, freshness agents or mixtures thereof.
  • optical agents such as coloring agents like whitening agents and pigments.
  • the pigment when used, is violet or blue having a hue angle, h, in the CI ELAB system of from 220 to 320 degrees.
  • These pigments may be selected from one or more of those listed in the Colour Index International, listed as pigment blue 1 through to pigment blue 83, and pigment violet 1 through to pigment violet 56.
  • the optical agents may be selected from one or more of mica, interference mica, boron nitride, poly(methyl methacrylate) flake, composite microspheres, titanium dioxide coated glass flake, inverse opal, cholesteric liquid crystal, photonic sphere, hollow sphere and zinc oxide.
  • Biomineralization agents for tooth enamel remineralization may be selected from one or more of fluoride sources, biomolecules, proteinaceous materials, amorphous calcium phosphate, otricalcium phosphate, ⁇ -tricalcium phosphate, calcium deficient hydroxyapatite Caio-x(HP04)x(P04)6-x(OH)2-x, 0 ⁇ x ⁇ 1 ), dicalcium phosphate (CaHPC ), dicalcium phosphate dihydrate (CaHP04-2H20), hydroxyapatite
  • Antibacterial agents may be selected from one or more of metal salts where the metal is selected from zinc, copper, silver or a mixture thereof, triclosan, triclosan monophosphate, triclocarban, curcumin, quaternary ammonium compounds, bisbiguanides and long chain tertiary amines, preferably zinc salts including zinc oxide, zinc chloride, zinc acetate, zinc ascorbate, zinc sulphate, zinc nitrate, zinc citrate, zinc lactate, zinc peroxide, zinc fluoride, zinc ammonium sulfate, zinc bromide, zinc iodide, zinc gluconate, zinc tartarate, zinc succinate, zinc formate, zinc phenol sulfonate, zinc salicylate, zinc glycerophosphate or a mixture thereof.
  • the metal is selected from zinc, copper, silver or a mixture thereof, triclosan, triclosan monophosphate, triclocarban, curcumin, quaternary ammonium compounds,
  • Gum health agents may be selected from one or more of anti- inflammatory agents, plaque buffers, biomolecules, proteinaceous materials, vitamin, plant extracts and curcumin.
  • Freshness agents may be flavors selected from one or more of peppermint, spearmint, menthol, flora oil, clove oil and citrus oil.
  • the benefit agent is preferably particulate as this allows for maximum surface area for contact with dental tissue.
  • the benefit agent is a particulate whitening agent for tooth whitening.
  • the particulate whitening agent comprises a material suitable to physically and immediately improve characteristics of teeth and especially whiten teeth.
  • the material is preferred to have a high refractive index of at least 1.9, more preferably at least 2.0, even more preferably at least 2.2, even more preferably still at least 2.4 and most preferably at least 2.5.
  • the maximum refractive index of the material is not particularly limited but preferably up to 4.0.
  • the material has a refractive index ranging from 1 .9 to 4.0.
  • metal compounds are metal compounds and preferred are compounds where the metal is selected from zinc (Zn), titanium (Ti), zirconium (Zr) or a combination thereof.
  • the metal compound is (or at least comprises) a metal oxide such as titanium dioxide (T1O2), zinc oxide (ZnO), zirconium dioxide (ZrC>2) or a combination thereof.
  • the particulate whitening agent can also comprise non-metal oxides such as strontium titanate and zinc sulfide.
  • the particulate whitening agent comprises metal oxides, non- metal oxides or a combination thereof in an amount of at least 50% by weight of the whitening agent and more preferably at least 70%, more preferably still from 80 to 100% and most preferably from 85 to 95%.
  • the particulate whitening agent is at least 50% by weight titanium dioxide, and most preferably, from 60 to 100% by weight titanium dioxide, based on total weight of the whitening agent and including all ranges subsumed therein.
  • the particulate whitening agents are slightly soluble or insoluble in water, but most preferably, insoluble in water.
  • the particulate whitening agents are composite particles. The refractive index of a composite particle comprising more than one material can be calculated based on the refractive indices and volume fractions of the constituents using effective medium theory, as is described for example in WO 2009/023353.
  • the composite particle comprises a first component core and a second component coating.
  • the core of the composite particle comprises a material suitable to physically and immediately improve characteristics of teeth and especially whiten teeth.
  • the material is preferred to have a high refractive index of at least 1.9, more preferably at least 2.0, even more preferably at least 2.2, even more preferably still at least 2.4 and most preferably at least 2.5.
  • the maximum refractive index of the material is not particularly limited but preferably up to 4.0.
  • the material has a refractive index ranging from 1.9 to 4.0.
  • suitable materials are metal compounds and preferred are compounds where the metal is selected from zinc (Zn), titanium (Ti), zirconium (Zr) or a combination thereof.
  • the metal compound is (or at least comprises) a metal oxide such as titanium dioxide (T1O2), zinc oxide (ZnO), zirconium dioxide (ZrC>2) or a combination thereof.
  • the core of the composite particle can also comprise non-metal oxides such as strontium titanate and zinc sulfide.
  • the core of the composite particle typically makes up from 3 to 98%, and preferably from 6 to 65%, and most preferably from 10 to 55% by weight of the composite particle, based on total weight of the composite particle and including all ranges subsumed therein.
  • the core comprises metal oxides, non-metal oxides or a combination thereof in an amount of at least 50% by weight of the core and more preferably at least 70%, more preferably still from 80 to 100% and most preferably from 85 to 95%.
  • the core is at least 50% by weight titanium dioxide, and most preferably, from 60 to 100% by weight titanium dioxide, based on total weight of the first component core.
  • the second component coating comprises material suitable to adhere to tooth enamel, dentin or both.
  • the second component coating is suitable to interact with phosphate ions to produce calcium and phosphate in situ reaction products that adhere well to tooth enamel, dentin or both.
  • the coating material comprises the element calcium, and optionally, other metals like potassium, sodium, aluminium, magnesium as well as mixtures thereof whereby such optional metals are provided as, for example, sulphates, lactates, oxides, carbonates or silicates.
  • the coating material may be aluminium oxide or silica.
  • the coating material is suitable to provide a biological or chemical improvement to teeth which is long term (e.g., results in hydroxyapatite formation).
  • the coating employed comprises at least 50% by weight elemental calcium, and most preferably, at least 65% by weight elemental calcium based on total weight of metal in the coating.
  • the metal in the coating is from 80 to 100% by weight of elemental calcium, based on total weight of metal in the second component coating and including all ranges subsumed therein.
  • the core and the coating are slightly soluble or insoluble in water, but most preferably, insoluble in water.
  • the second component coating can comprise, for example, calcium phosphate, calcium oxide, calcium carbonate, calcium hydroxide, calcium sulphate, calcium carboxymethyl cellulose, calcium alginate, calcium salts of citric acid, calcium silicate, mixture thereof or the like.
  • the calcium source in the coating comprises calcium silicate.
  • the coating can comprise the element calcium which originates from insoluble calcium silicate, present as the composite material calcium oxide-silica (CaO-SiC>2) as described in international patent applications published as WO 2008/0151 17 and WO 2008/068248.
  • the ratio of calcium to silicon (Ca:Si) may be from 1 : 10 to 3: 1 .
  • the Ca:Si ratio is preferably from 1 :5 to 3: 1 , and more preferably, from 1 :3 to 3: 1 , and most preferably, from about 1 :2 to 3: 1 .
  • the calcium silicate may comprise mono-calcium silicate, bi-calcium silicate, or tri-calcium silicate whereby ratios of calcium to silicon (Ca:Si) should be understood to be atom ratios
  • the particulate whitening agent is titanium dioxide coated with calcium silicate.
  • the particulate whitening agent according to the present invention can be of different sizes and shapes.
  • the particles may be of spherical, platelet or irregular shape form.
  • the diameter of the particulate whitening agent is often from 10 nm to less than 50 microns, and preferably, from 75 nm to less than 10 microns. In an especially preferred
  • the diameter of particles is from 100 nm to 5 microns, including all ranges subsumed therein.
  • Particle size can be measured, for example, by dynamic light scattering (DLS).
  • DLS dynamic light scattering
  • the oral care composition of the present invention may comprise a single benefit agent or a mixture of two or more benefit agents.
  • the benefit agent is present in an amount from 0.25 to 60%, and more preferably, from 0.5 to 40%, and most preferably, from 1 to 30% by total weight of the oral care composition and including all ranges subsumed therein.
  • the relative weight ratio of the water insoluble and/or slightly soluble calcium source to the benefit agent typically ranges from 1 :10 to 30:1 , more preferably from 1 :5 to 10:1 , most preferably from 1 :3 to 5:1 .
  • the oral care composition of the present invention is found to be effective in blocking dentinal tubules to reduce tooth sensitivity.
  • the present inventors believe that this may be because the water insoluble and/or slightly soluble calcium source reacts with the phosphate source to form calcium phosphate that may have an affinity for dentine and/or enamel of teeth.
  • the presence of water soluble calcium source in the present invention may increase the calcium ion concentration in the oral composition to enhance the reaction between the calcium source and the phosphate source in the mouth to induce in situ generation of calcium phosphate that occludes the dentinal tubules and/or their open ends, which enhances the tubule blockage efficacy.
  • benefit agents are included in the oral care composition, the remineralization of the calcium source around the benefit agents further helps the retention of those benefit agents on tooth surfaces by enhancing their resistance to shear force.
  • the oral care composition of the present invention may contain a variety of other ingredients which are common in the art to enhance physical properties and performance. These ingredients include preservatives, pH-adjusting agents, sweetening agents, particulate abrasive materials, polymeric compounds, buffers and salts to buffer the pH and ionic strength of the compositions, and mixtures thereof. Such ingredients typically and collectively make up less than 20% by weight of the composition, and preferably, from 0.0 to 15% by weight, and most preferably, from 0.01 to 12% by weight of the composition, including all ranges subsumed therein.
  • the oral care composition of this invention can be used in a method for benefiting teeth of an individual comprising applying in the composition to at least one surface of the teeth of an individual, said benefits includes reduced sensitivity, remineralization, whitening and combinations thereof.
  • the oral care composition of this invention may additionally or alternatively be for use as a medicament and/or used in the manufacture of a
  • medicament for providing an oral care benefit as described herein such as for reducing sensitivity of the teeth of an individual.
  • the use is non- therapeutic.
  • the oral care composition is a monophase anhydrous composition.
  • the composition is substantially free of water to prevent the premature reaction between the calcium source and the phosphate source.
  • the oral care composition is a dual-phase composition comprising a calcium phase and a phosphate phase, wherein the water insoluble and/or slightly soluble calcium source and the water soluble calcium source are present in the calcium phase and the phosphate source is present in the phosphate phase.
  • the two phases are physically separate from one another by being in independent phases.
  • the delivery of the two independent phases to the teeth may be simultaneous or sequential. In a preferred embodiment, the phases are delivered simultaneously.
  • water may act as a carrier (along with thickeners and/or additional carriers herein described) and make up the balance of each phase in the dual- phase composition.
  • the calcium phase and the phosphate phase should not come into contact with each other until dispensed for use. In use, it is preferably to combine the two phases to form a mix prior to their application to the teeth.
  • the weight ratio of the calcium phase and the phosphate phase in this mix is from 1 :3 to 10: 1 , more preferably from 1 :2 to 7:1 , most preferably from 1 : 1 .5 to 5:1 .
  • the dual-phase composition is delivered by a dual-tube having a first compartment for calcium phase and a second compartment for phosphate phase, which allows for co-extrusion of the two phases.
  • such a dual-tube has one of the compartments surrounding the other.
  • one phase is present as a sheath, surrounding the other phase in the core.
  • the core is the calcium phase and the sheath is the phosphate phase.
  • such a dual-tube has the two compartments side by side within the same tube.
  • the two phases are extruded from the tube as one, such extrusion being termed "contact extrusion".
  • a pump head may be used in such a dual-tube for squeezing the two phases from the tube as one.
  • the dual-phase oral care composition may be a gel composition that comprises two independent gel phases, the first is the calcium phase and the second is the phosphate phase.
  • the means of delivery may involve a cotton rod, or a tray, onto which the calcium phase and the phosphate phase are applied, prior to the tray being placed in contact with the teeth.
  • the oral care composition of the present invention is prepared by conventional methods of making oral care compositions. Such methods include mixing the ingredients under moderate shear and atmospheric pressure.
  • the composition will be packaged.
  • tooth paste or gel form the composition may be packaged in a conventional plastic laminate, metal tube or a single compartment dispenser. The same may be applied to dental surfaces by any physical means, such as a toothbrush, fingertip or by an applicator directly to the sensitive area.
  • liquid mouthwash form the composition may be packaged in a bottle, sachet or other convenient container.
  • the composition can be effective even when used in an individual's daily oral hygiene routine.
  • the composition may be brushed onto the teeth.
  • the composition may, for example, be contacted with the teeth for a time period of one second to 20 hours. More preferably from 1 s to 10 hours, more preferably still from 10 s to 1 hour and most preferably from 30 s to 5 minutes.
  • the composition may be used daily, for example for use by an individual once, twice or three times per day.
  • the oral care composition is a dual-phase composition
  • the two phases of the composition are mixed during application.
  • the mixed phases are typically left on the teeth for from 3 minutes to 10 hours, more preferably from 3 minutes to 8 hours.
  • the application may be carried out one to five times monthly.
  • This example demonstrates the improved blockage of dentinal tubules by using a water insoluble and/or slightly soluble calcium source in combination with a water soluble calcium source and a phosphate source. All ingredients are expressed by amount of the total formulation, and as level of active ingredient.
  • Dl de-ionised
  • the discs were then soaked in simulated oral fluid (SOF) for more than 3 hours under the condition of a shaking water bath at 37°C and 60.0 rpm. After that, the dentine discs were brushed with fresh made slurries by machine using the same procedure as in the first step. The brushing was repeated three times for one day, then the dentine discs were kept in SOF overnight(>12 hours) in a shaking water bath at 37°C to mimic oral environment.
  • the dentine samples were characterized by scanning electron microscopy (SEM, Hitachi S-4800, Japan) after 3 brushings.
  • a square (with a size of 4mm x 4mm) is selected and one image is captured under 50x magnification. Within this square, five spots (each with a size of 150 ⁇ x 150 ⁇ , one in the middle, and one in every corner) are selected and observed under 1000x magnification.
  • the blockage of tubules are accessed following the standards described in Table 3. The measurement is carried out for the two dentine discs of each test group.
  • Samples 4 and 5 comprising a combination of a water soluble calcium source, a water insoluble and/or slightly soluble calcium source and a phosphate source showed significantly better tubule blockage efficacy than other samples (p ⁇ 0.01 ), all the dentinal tubules were blocked.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition de soin bucco-dentaire comprenant une source de calcium insoluble et/ou légèrement soluble dans l'eau, une source de calcium soluble dans l'eau, une source de phosphate et un support physiologiquement acceptable, la source de calcium insoluble et/ou légèrement soluble dans l'eau comprenant du carbonate de calcium, de l'aluminate de calcium, de l'oxalate de calcium, du silicate de calcium d'aluminium, de l'oxyde de calcium, de la carboxyméthylcellulose de calcium, de l'alginate de calcium, de l'hydroxyde de calcium, du sulfate de calcium, des sels de calcium d'acide citrique ou des mélanges de ceux-ci, et la source de calcium insoluble et/ou légèrement soluble dans l'eau et la source de calcium soluble dans l'eau étant présentes dans un rapport pondéral (a:b) de 1:3 à 20:1, la source de calcium insoluble et/ou légèrement soluble dans l'eau ayant une taille de particule D50 de 0,01 à 3 microns, et la source de phosphate étant du phosphate trisodique, du dihydrogénophosphate monosodique, de l'hydrogénophosphate disodique, du phosphate d'ammonium, de l'hydrogénophosphate de diammonium, du dihydrogénophosphate d'ammonium, du phosphate tripotassique, du dihydrogénophosphate monopotassique, de l'hydrogénophosphate dipotassique ou un mélange de ceux-ci.
PCT/EP2018/069990 2017-08-18 2018-07-24 Composition de soin bucco-dentaire WO2019034377A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN201880060433.2A CN111093603B (zh) 2017-08-18 2018-07-24 口腔护理组合物
BR112020002930-0A BR112020002930B1 (pt) 2017-08-18 2018-07-24 Composição de cuidados orais e uso de uma composição de cuidados orais
EA202090522A EA202090522A1 (ru) 2017-09-18 2018-07-24 Композиция для ухода за полостью рта
EP18742507.9A EP3668478B1 (fr) 2017-08-18 2018-07-24 Composition d'hygiène buccale
PH12020500258A PH12020500258A1 (en) 2017-08-18 2020-02-05 Oral care composition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CNPCT/CN2017/098035 2017-08-18
CN2017098035 2017-08-18
EP17191670.3 2017-09-18
EP17191670 2017-09-18

Publications (1)

Publication Number Publication Date
WO2019034377A1 true WO2019034377A1 (fr) 2019-02-21

Family

ID=62948135

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2018/069990 WO2019034377A1 (fr) 2017-08-18 2018-07-24 Composition de soin bucco-dentaire

Country Status (5)

Country Link
EP (1) EP3668478B1 (fr)
CN (1) CN111093603B (fr)
CL (1) CL2020000330A1 (fr)
PH (1) PH12020500258A1 (fr)
WO (1) WO2019034377A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11529295B2 (en) 2019-09-25 2022-12-20 Church & Dwight Co., Inc. Oral care composition

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09295924A (ja) * 1996-04-30 1997-11-18 Lion Corp 歯垢の酸中和剤及び口腔用組成物
JPH11130643A (ja) * 1997-10-28 1999-05-18 Lion Corp 口腔用組成物
US20040161388A1 (en) * 2003-02-13 2004-08-19 Sung-Tsuen Liu Precipitated calcium carbonate
WO2008015117A2 (fr) 2006-08-01 2008-02-07 Unilever Plc Biomatériaux, leur préparation et leur utilisation
WO2008068248A1 (fr) 2006-12-05 2008-06-12 Unilever Plc Produit de soin buccal
WO2009023353A1 (fr) 2007-05-23 2009-02-19 Carnegie Mellon University Structures composites de particule hybride avec une diffusion réduite
EP2349189B1 (fr) * 2008-11-14 2015-08-05 Swissdent Cosmetics AG Composition de soin oral biomimétique
EP2926797A1 (fr) * 2014-03-31 2015-10-07 Omya International AG Carbonate de calcium traité par réaction en surface pour la reminéralisation et le blanchiment des dents
WO2016082742A1 (fr) * 2014-11-24 2016-06-02 Hawley & Hazel Chemical Co. (Zhongshan) Ltd. Composition dentaire anti-sensibilité
WO2016180620A1 (fr) * 2015-05-13 2016-11-17 Unilever N.V. Composition de soins bucco-dentaires
WO2016180601A1 (fr) * 2015-05-13 2016-11-17 Unilever N.V. Composition d'hygiène bucco-dentaire
WO2017080687A1 (fr) * 2015-11-10 2017-05-18 Unilever N.V. Composition de soin oral

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013034421A2 (fr) * 2011-09-08 2013-03-14 Unilever N.V. Dentifrice de reminéralisation dentaire
CN105517633B (zh) * 2013-09-10 2019-06-18 荷兰联合利华有限公司 口腔护理组合物

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09295924A (ja) * 1996-04-30 1997-11-18 Lion Corp 歯垢の酸中和剤及び口腔用組成物
JPH11130643A (ja) * 1997-10-28 1999-05-18 Lion Corp 口腔用組成物
US20040161388A1 (en) * 2003-02-13 2004-08-19 Sung-Tsuen Liu Precipitated calcium carbonate
WO2008015117A2 (fr) 2006-08-01 2008-02-07 Unilever Plc Biomatériaux, leur préparation et leur utilisation
WO2008068248A1 (fr) 2006-12-05 2008-06-12 Unilever Plc Produit de soin buccal
WO2008068149A1 (fr) 2006-12-05 2008-06-12 Unilever Plc Produit de soin buccal
WO2009023353A1 (fr) 2007-05-23 2009-02-19 Carnegie Mellon University Structures composites de particule hybride avec une diffusion réduite
EP2349189B1 (fr) * 2008-11-14 2015-08-05 Swissdent Cosmetics AG Composition de soin oral biomimétique
EP2926797A1 (fr) * 2014-03-31 2015-10-07 Omya International AG Carbonate de calcium traité par réaction en surface pour la reminéralisation et le blanchiment des dents
WO2016082742A1 (fr) * 2014-11-24 2016-06-02 Hawley & Hazel Chemical Co. (Zhongshan) Ltd. Composition dentaire anti-sensibilité
WO2016180620A1 (fr) * 2015-05-13 2016-11-17 Unilever N.V. Composition de soins bucco-dentaires
WO2016180601A1 (fr) * 2015-05-13 2016-11-17 Unilever N.V. Composition d'hygiène bucco-dentaire
WO2017080687A1 (fr) * 2015-11-10 2017-05-18 Unilever N.V. Composition de soin oral

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11529295B2 (en) 2019-09-25 2022-12-20 Church & Dwight Co., Inc. Oral care composition

Also Published As

Publication number Publication date
EP3668478B1 (fr) 2022-04-13
EP3668478A1 (fr) 2020-06-24
CL2020000330A1 (es) 2020-09-25
BR112020002930A2 (pt) 2020-08-11
PH12020500258A1 (en) 2020-09-14
CN111093603A (zh) 2020-05-01
CN111093603B (zh) 2023-04-11

Similar Documents

Publication Publication Date Title
EP3668477A1 (fr) Composition pour soins buccaux
EP3668604B1 (fr) Composition de soins bucco-dentaires
EP3648731B1 (fr) Composition d'hygiène buccale
EP3528773A1 (fr) Composition de soin bucco-dentaire
EP3547989B1 (fr) Composition de protection orale
EP3614993B1 (fr) Composition de protection orale comprenant de l'oxyde de zinc de l'hydrogenophosphate de calcium
EP3554459B1 (fr) Composition de protection orale
EP3500232B1 (fr) Composition de protection orale
WO2019029917A1 (fr) Composition pour soins buccaux
EP3668478B1 (fr) Composition d'hygiène buccale
WO2022089927A1 (fr) Composition de soin buccal
WO2020099068A1 (fr) Composition de soins buccaux
WO2021047900A1 (fr) Composition de soin buccal
WO2017198399A1 (fr) Composition de soin bucco-dentaire comprenant du silicate tricalcique
EP3614994B1 (fr) Composition de protection orale
EA042242B1 (ru) Композиция для ухода за полостью рта
EA039810B1 (ru) Композиция для ухода за полостью рта на основе оксида цинка и дигидрофосфата кальция
WO2022184874A1 (fr) Composition de soin buccal
BR112020003065B1 (pt) Composição de cuidado oral, método para beneficiar dentes de um indivíduo e uso de uma composição de cuidado oral
BR112020002930B1 (pt) Composição de cuidados orais e uso de uma composição de cuidados orais
EA039652B1 (ru) Композиция для ухода за полостью рта
EA038664B1 (ru) Композиция для ухода за полостью рта
EP3458016A1 (fr) Composition de soin bucco-dentaire comprenant du silicate tricalcique
EA042995B1 (ru) Композиция для ухода за полостью рта

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18742507

Country of ref document: EP

Kind code of ref document: A1

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112020002930

Country of ref document: BR

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018742507

Country of ref document: EP

Effective date: 20200318

ENP Entry into the national phase

Ref document number: 112020002930

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20200211